Jasper Therapeutics, Inc.

JSPRReported to SECin USCIK 0001788028Filings at SEC EDGAR

JSPR is one of 2 listed share classes under this CIK; the filings below cover all of them.

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 6. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 6
Form 4 lines at Jasper Therapeutics, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
WIGGANS THOMAS G—Awardnothing paid7,500 sharesAug 4, 2026WIGGANS THOMAS Gnothing paidAward · Aug 4Award7,500Aug 4, 2026
Lucas Svetlana—Awardnothing paid7,500 sharesAug 4, 2026Lucas Svetlananothing paidAward · Aug 4Award7,500Aug 4, 2026
Crutcher Patrick J—Awardnothing paid7,500 sharesAug 4, 2026Crutcher Patrick Jnothing paidAward · Aug 4Award7,500Aug 4, 2026
EMSTER KURT VON—Awardnothing paid7,500 sharesAug 4, 2026EMSTER KURT VONnothing paidAward · Aug 4Award7,500Aug 4, 2026
Shizuru Judith Anne—Awardnothing paid7,500 sharesAug 4, 2026Shizuru Judith Annenothing paidAward · Aug 4Award7,500Aug 4, 2026